AAHFN 13th Annual Meeting

Pharmacology Workshop Information

 

Symptom Management of the Heart Failure Patient

The primary goal of drug therapy in heart failure is to improve cardiac function but also to improve and reduce the clinical symptoms associated with heart failure. Being able to identify and provide appropriate patient-specific pharmacotherapy for heart failure associated clinical symptoms is essential to enhancing both patient outcomes and quality of life.

By taking a symptoms management approach, this state-of-the-art, multidisciplinary preconference is designed to provide the most up-to-date, evidenced based treatment strategies for the management of heart failure.

Come join your colleagues for this innovative, interactive preconference as we critically evaluate and dive into heart failure pharmacotherapy/pharmacology from a case-based, clinical symptoms perspective.

 

Wednesday, June 21, 2017

 8:00 am – 8:15 am

Welcome
Peggy Kirkwood, RN, MSN, ACNPC, AACC, CHFN
Mission Hospital
Laguna Hills, CA

Robert Lee Page II, Pharm.D., MSPH, FCCP, FAHA, FASHP, FASCP, BCPS, CGP
University of Colorado, Skaggs School of Pharmacy
Aurora, CO

  8:15 am – 9:30 am

Assessment and Etiology of Symptoms
Rebecca Boxer, MD, MS
University of Colorado 
Aurora, CO

Objectives:
1. Identify the symptoms seen in heart failure patients, including dyspnea, fatigue, pain, anxiety,
depression, and end-of-life symptoms.
2. Describe the assessment of symptoms in the heart failure patient, including physical assessment
as well as cognition and health literacy assessment.
3. Discuss the pathophysiology of the symptoms, including the activation of RAAS, sleep disordered
breathing.

  9:30 am – 10:00 am Case Study
10:00 am – 10:15 am Break
10:15 am – 11:00 am Fatigue – Part 1 (dehydration, electrolytes, infection)
Linda Wick, MS, ANP, CNP, CHFN
University of Minnesota Health
Duluth, MN


Objectives:
1. Describe the effects of cardiac dysfunction, dehydration, electrolyte disturbance, and
infections on the symptom of fatigue in the heart failure patient.
2. Discuss the treatment of cardiac dysfunction, dehydration, electrolyte disturbance and
infections in the heart failure patient, including the use of neurohormone inhibitors, potassium
lowering medications, and fluids related to sepsis protocols.
11:00 am – 11:45 am Fatigue – Part 2 (Anemia, Thyroid, Afib)
Sunny Linnebur, PharmD
University of Colorado
Aurora, CO


Objectives:
1. Describe the effects of anemia, thyroid dysfunction, and atrial fibrillation on the symptom of
fatigue in the heart failure patient.
2. Discuss the treatment of anemia, thyroid dysfunction, and atrial fibrillation in the heart
failure patient, including iron, anticoagulants, and antiarrhythmics.
11:45am – 12:15 pm Case Study
12:15 pm – 1:00 pm Lunch
  1:00 pm – 2:30 pm Dyspnea & Edema
Jo Ellen Rodgers, PharmD, FCCP, BCPS-AQ Cardiology
University of North Carolina at Chapel Hill
Chapel Hill, NC


Objectives:
1. Explain the possible treatments for dyspnea and edema in the heart failure patient.
2. Discuss the use of diuretics in the heart failure patient, including titration, infusion vs.
bolus, outpatient infusions.
3. Define the use of afterload reducers and inotropes to decrease dyspnea and edema.
4. Describe the treatment of stage D heart failure patients, especially at end-of-life.
 2:30 pm – 3:00 pm Case Study
 3:00 pm – 3:15 pm Break
 3:15 pm – 4:00 pm Pain – angina, fractures, arthritis, PAD, etc.
Peggy Kirkwood, RN, MSN, ACNPC, AACC, CHFN
Mission Hospital
Laguna Hills, CA


Objectives:
1. Describe the types of pain heart failure patients may experience, including angina, arthritis,
PAD, fractures.
2. Discuss various treatment options for pain in the heart failure patient, including antianginals,
NSAIDS, opioids, bisphosphonates, marijuana.
3. Identify therapies helpful for heart failure patients with pain at end- of-life, including
alternative therapies.
 4:00 pm – 4:45pm Anxiety/Depression/Fear/PTSD
Robert Lee Page II, PharmD, MSPH, FCCP, FAHA, FASHP, FASCP, BCPS, CGP
University of Colorado, Skaggs School of Pharmacy
Aurora, CO


Objectives
1. Describe the types of psychologic disorders that heart failure patients may experience,
including anxiety, depression, fear, PTSD.
2. Discuss the various treatment options for psychologic disorders in the heart failure patient.
 4:45 pm – 5:00 pm Q&A and Wrap up


This activity is approved 7.5 contact hour(s) of continuing education (which includes 7.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 17042657. This activity was planned in accordance with AANP CE Standards and Policies.